Aleksandra Rizo's Insider Trades & SAST Disclosures
Aleksandra Rizo's most recent trade in Syndax Pharmaceuticals Inc was a trade of 25,000 Common Stock done . Disclosure was reported to the exchange on Feb. 5, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Aleksandra Rizo.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Syndax Pharmaceuticals Inc | Aleksandra Rizo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 25,000 | 25,000 (0%) | 0% | 0 | Common Stock | |
| Syndax Pharmaceuticals Inc | Aleksandra Rizo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 35,000 | 35,000 | - | - | Stock Options (Right to buy) | |
| Geron Corp. | Aleksandra Rizo | EVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2022 | 750,000 | 750,000 | - | - | Employee Stock Option (right to buy) | |
| Geron Corp. | Aleksandra Rizo | EVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2021 | 300,000 | 300,000 | - | - | Employee Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges